Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1980 Apr;56(654):261–262. doi: 10.1136/pgmj.56.654.261

Dantrolene and lymphocytic lymphoma.

H H Wan, J S Tucker
PMCID: PMC2425904  PMID: 6893628

Abstract

A patient is reported who was on prolonged treatment with dantrolene for spastic paraplegia; he developed a malignant lymphoma which led to his death.

Full text

PDF
261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anthony J. J. Malignant lymphoma associated with hydantoin drugs. Arch Neurol. 1970 May;22(5):450–454. doi: 10.1001/archneur.1970.00480230068008. [DOI] [PubMed] [Google Scholar]
  2. Gams R. A., Neal J. A., Conrad F. G. Hydantoin-induced pseudo-pseudolymphoma. Ann Intern Med. 1968 Sep;69(3):557–568. doi: 10.7326/0003-4819-69-3-557. [DOI] [PubMed] [Google Scholar]
  3. Hyman G. A., Sommers S. C. The development of Hodgkin's disease and lymphoma during anticonvulsant therapy. Blood. 1966 Sep;28(3):416–427. [PubMed] [Google Scholar]
  4. SALTZSTEIN S. L., ACKERMAN L. V. Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas. Cancer. 1959 Jan-Feb;12(1):164–182. doi: 10.1002/1097-0142(195901/02)12:1<164::aid-cncr2820120122>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES